Company news

Avacta Group PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Launch of SARS-CoV-2 BAMS Research Test

September 30, 2020

Interim Results for the Period Ended 30 June 2020

September 28, 2020

Update on Integumen Collaboration

September 24, 2020

Avacta to Launch SARS-CoV-2 ELISA Laboratory Test

September 7, 2020

Expansion of COVID-19 Test Manufacturing Capacity

September 2, 2020

Expanded Partnership with LG Chem Life Sciences

August 18, 2020

Clarification Regarding Medusa 19 Antibody Test

August 17, 2020

Therapeutics Chief Development Officer Appointment

August 11, 2020

SARS-CoV-2 Antigen Test Clinical Collaboration

August 7, 2020

COVID-19 Rapid Antigen Test Manufacturing Partner

August 6, 2020

Expanded Partnership with Daewoong Pharmaceutical

July 29, 2020

Update on Adeptrix COVID-19 Diagnostic Test

July 22, 2020

Collaboration with Integumen plc

July 13, 2020

Update on COVID-19 Test Development Partnership

June 24, 2020

Update on Affimer® Therapy for COVID-19 Infection

June 18, 2020

Investor Presentation

June 9, 2020

Update on COVID-19 Test Development with Adeptrix

June 9, 2020

Posting of Circular and Notice of General Meeting

June 8, 2020

Result of Fundraising

June 4, 2020

Increase in Fundraising

June 4, 2020

PrimaryBid.com Offers

June 4, 2020

Proposed Fundraising to raise up to £45 million

June 4, 2020

Distribution Agreement for COVID-19 Antigen Test

May 20, 2020

SARS-COV-2 Neutralising Affimers

May 15, 2020

Avacta Ships SARS-COV-2 Affimer Reagents

May 11, 2020

Results for the period ending 31 December 2019

May 6, 2020

COVID-19 Antigen Test Collaboration with Adeptrix

May 1, 2020

Avacta/Cytiva Partnership Ahead of Schedule

April 22, 2020

Notice of Results - Update

April 17, 2020

Avacta & Cytiva Collaborate on COVID-19 Rapid Test

April 8, 2020

Proposed Placing to raise £3.75 million

April 6, 2020

Subscription to raise £2 million

April 2, 2020

Shareholder/Investor Meeting and Presentation

March 10, 2020

Avacta and Daewoong Agreement

February 3, 2020

Successful initial proof-of-concept

January 28, 2020

Trading Update

January 23, 2020

Avacta and Daewoong Establish Joint Venture

January 8, 2020

LG Chem Life Sciences Expands Partnership

November 13, 2019

Proposed Placing & Subscription to raise up to £9M

October 18, 2019

Interim Results for the Period Ended 31 July 2019

October 18, 2019

Collaboration with ADC Therapeutics

October 10, 2019

Avacta's CEO to Present at Biotech Investor Day

July 29, 2019

Avacta and Selexis Partner to Develop Cell Line

June 20, 2019

Turner Pope Investor Evening

June 19, 2019

Avacta's CSO to Present at Major US Conference

June 12, 2019

Avacta hits Clinical Candidate Selection Milestone

June 10, 2019

TMAC Programme Accelerates

June 3, 2019

Avacta (AVCT): A second wake-up call for the ma...

February 6, 2019

Moderna Exercises Exclusive Product License Option

February 4, 2019

AGM Business Update and Notice of Results

January 21, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 21 calls. Every call is listed under its year.

Decks

The 5 newest of 18 decks. Every deck is listed under its year.